Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1992 1
1999 1
2000 1
2003 2
2006 1
2008 1
2010 1
2013 1
2014 3
2015 2
2016 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
The dysexecutive syndromes.
Daffner KR, Searl MM. Daffner KR, et al. Among authors: searl mm. Handb Clin Neurol. 2008;88:249-67. doi: 10.1016/S0072-9752(07)88012-2. Handb Clin Neurol. 2008. PMID: 18631695 No abstract available.
Uranium resources.
Searl MF, Platt J. Searl MF, et al. Science. 1977 May 6;196(4290):603-4. doi: 10.1126/science.196.4290.603. Science. 1977. PMID: 17760033 No abstract available.
IQ-based norms for highly intelligent adults.
Rentz DM, Sardinha LM, Huh TJ, Searl MM, Daffner KR, Sperling RA. Rentz DM, et al. Among authors: searl mm. Clin Neuropsychol. 2006 Dec;20(4):637-48. doi: 10.1080/13854040500477498. Clin Neuropsychol. 2006. PMID: 16980251
ACT for migraine: effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: preliminary data of a phase-II, multicentric, randomized, open-label study.
Grazzi L, Bernstein C, Raggi A, Sansone E, Grignani E, Searl M, Rizzoli P. Grazzi L, et al. Among authors: searl m. Neurol Sci. 2019 May;40(Suppl 1):191-192. doi: 10.1007/s10072-019-03802-w. Neurol Sci. 2019. PMID: 30854584 Clinical Trial. No abstract available.
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Liu E, et al. Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24. Neurology. 2015. PMID: 26208959 Free PMC article. Clinical Trial.
17 results